Subcutaneous administration of AMD3100 into mice models of Alzheimer’s disease ameliorated cognitive impairment, reduced neuroinflammation, and improved pathophysiological markers

Manuscript Number: 

20-0506R4

Author(s): 
Becki Barbiro, Assaf Ezra, Yuval Gavriel, Inna Rabinovich-Nikitin, Beka Solomon

Disclosures

Becki Barbiro

  • Nothing to Disclose

Assaf Ezra

  • Nothing to Disclose

Yuval Gavriel

  • Nothing to Disclose

Inna Rabinovich-Nikitin

  • Nothing to Disclose

Beka Solomon

  • Nothing to Disclose